UGA Researchers Break Ground on Flu Vaccine

Researchers at the University of Georgia and Sanofi Pasteur, a multinational pharmaceutical company announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a technique called Computationally Optimized Broadly Reactive Antigen, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.

Sanofi Pasteur and UGA researchers are set to present their data tomorrow, March 30, at the World Vaccine Congress located in Washington, D.C.

Tags:

You May Also Like

Autism Awareness Month: How One Local Family Is Affected

ELBERTON — April marks Autism Awareness Month. According to the CDC, 1 in 68 ...

UGA Organization Spreads the Word about Pollen with Beer

Athens, GA- Without bees, beer would not exist. Terrapin Events Coordinator Jessica Merritt says, ...

UGA Spring Career Fair Sets Recruiter Attendance Records

Athens, GA — This year’s Spring Career Fair filled the Classic Center to capacity. ...